New grant awarded to UCM’s Andrew Aronsohn, MD and Daniel Johnson, MD

October 27, 2014

Daniel Johnson, MD (left) and Andrew Aronsohn, MD

Two UCM physicians receive CDC grant to increase community’s capacity to diagnose and treat hepatitis C. 

Congratulations to the University of Chicago Medicine’s Andrew Aronsohn, MD, a specialist in the diagnosis and management of liver diseases, and Daniel Johnson, MD, an expert in pediatric infectious diseases, who have received a grant from the Center for Disease Control and Prevention to develop a community alliance for the testing and treatment of hepatitis C in Chicago. With this funding, a coalition of stakeholders will develop and implement services for a target population with HCV-related health disparities. One of the goals is to increase the capacity of primary care providers to diagnose and cure hepatitis C virus (HCV) infection.